Macquarie On Cadila Health
O-P, TP Rs 292
Disappointed By Quantum Of Payout To CDH
Indian Pharma Cos Continue To Struggle With Monetisation Of Specialty Molecules
Zypitamag Has Had Slow Ramp-up So Far